Vertex Pharmaceuticals Inc (VRTX) Insider Trading
- $14,887,810.00
- $1,037,179,923.19
- March 13, 2026
- Joshua S Boger
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Oct. 27, 2014 | SVP | 1,125 | $110.03 | Sell | $123,783.75 | |
| Oct. 13, 2014 | SVP | 1,125 | $107.89 | Sell | $121,376.25 | |
| Oct. 7, 2014 | CMO | 3,436 | $104.26 | Sell | $358,237.36 | |
| Oct. 6, 2014 | Director | 1,405 | $109.75 | Sell | $154,198.75 | |
| Oct. 1, 2014 | Director | 5,000 | $107.74 | Sell | $538,700.00 | |
| Oct. 1, 2014 | EVP | 12,417 | $107.71 | Sell | $1,337,435.07 | |
| Sept. 30, 2014 | SVP | 86,000 | $112.68 | Sell | $9,690,480.00 | |
| Sept. 30, 2014 | CFO | 108,026 | $112.68 | Sell | $12,172,369.68 | |
| Sept. 30, 2014 | CEO | 200,000 | $112.69 | Sell | $22,538,000.00 | |
| Sept. 30, 2014 | EVP | 36,000 | $112.69 | Sell | $4,056,840.00 | |
| Sept. 29, 2014 | Director | 2,500 | $114.75 | Sell | $286,875.00 | |
| Sept. 24, 2014 | Director | 5,200 | $109.21 | Sell | $567,892.00 | |
| Sept. 19, 2014 | Director | 5,000 | $102.25 | Sell | $511,250.00 | |
| Sept. 19, 2014 | SVP | 25,408 | $99.85 | Sell | $2,536,988.80 | |
| Sept. 19, 2014 | EVP | 55,521 | $100.00 | Sell | $5,552,100.00 | |
| Sept. 17, 2014 | Director | 5,200 | $93.62 | Sell | $486,824.00 | |
| Sept. 10, 2014 | Director | 5,200 | $94.42 | Sell | $490,984.00 | |
| Sept. 5, 2014 | Director | 2,500 | $94.75 | Sell | $236,875.00 | |
| Sept. 3, 2014 | Director | 5,200 | $92.79 | Sell | $482,508.00 | |
| Aug. 27, 2014 | Director | 5,200 | $93.31 | Sell | $485,212.00 | |
| Aug. 20, 2014 | Director | 5,200 | $91.51 | Sell | $475,852.00 | |
| Aug. 13, 2014 | Director | 5,200 | $88.00 | Sell | $457,600.00 | |
| Aug. 6, 2014 | Director | 5,200 | $86.54 | Sell | $450,008.00 | |
| July 31, 2014 | Director | 5,000 | $89.59 | Sell | $447,950.00 | |
| July 31, 2014 | SVP | 2,027 | $88.97 | Sell | $180,342.19 | |
| July 30, 2014 | Director | 5,200 | $92.17 | Sell | $479,284.00 | |
| July 15, 2014 | Director | 4,800 | $96.65 | Sell | $463,920.00 | |
| July 1, 2014 | Director | 5,000 | $95.21 | Sell | $476,050.00 | |
| July 1, 2014 | EVP | 30,134 | $95.22 | Sell | $2,869,359.48 | |
| June 24, 2014 | Director | 15,000 | $98.03 | Sell | $1,470,450.00 | |
| June 24, 2014 | SVP | 12,734 | $98.03 | Sell | $1,248,314.02 | |
| June 16, 2014 | EVP | 7,500 | $68.31 | Sell | $512,325.00 | |
| June 9, 2014 | Director | 2,500 | $75.00 | Sell | $187,500.00 | |
| May 14, 2014 | EVP | 7,500 | $67.45 | Sell | $505,875.00 | |
| May 2, 2014 | SVP | 1,000 | $67.62 | Sell | $67,620.00 | |
| April 15, 2014 | EVP | 7,500 | $61.63 | Sell | $462,225.00 | |
| April 9, 2014 | Director | 2,500 | $70.00 | Sell | $175,000.00 | |
| March 21, 2014 | Director | 8,700 | $74.59 | Sell | $648,933.00 | |
| March 17, 2014 | EVP | 7,500 | $78.29 | Sell | $587,175.00 | |
| Feb. 7, 2014 | CEO | 35,944 | $80.00 | Sell | $2,875,520.00 | |
| Jan. 22, 2014 | Director | 8,300 | $84.47 | Sell | $701,101.00 | |
| Jan. 21, 2014 | SVP | 1,250 | $85.00 | Sell | $106,250.00 | |
| Jan. 16, 2014 | CEO | 45,000 | $80.00 | Sell | $3,600,000.00 | |
| Jan. 15, 2014 | EVP | 7,500 | $78.67 | Sell | $590,025.00 | |
| Dec. 23, 2013 | Director | 8,300 | $73.02 | Sell | $606,066.00 | |
| Dec. 16, 2013 | EVP | 7,500 | $64.69 | Sell | $485,175.00 | |
| Dec. 12, 2013 | SVP | 5,083 | $65.48 | Sell | $332,834.84 | |
| Dec. 12, 2013 | CEO | 9,834 | $65.48 | Sell | $643,930.32 | |
| Dec. 12, 2013 | EVP | 4,532 | $65.46 | Sell | $296,664.72 | |
| Dec. 4, 2013 | Director | 1,400 | $67.48 | Sell | $94,472.00 |
Insiders are both buying and selling Vertex Pharmaceuticals Inc stock.
The insider traders at Vertex Pharmaceuticals Inc are: Joshua S Boger, Paul M Silva, Stuart A Arbuckle, Amit Sachdev, Jeffrey M Leiden, Michael Parini, David Altshuler, Jeffrey Chodakewitz, Joshua S. Boger, Yuchun Lee, Ourania Tatsis, Reshma Kewalramani, Sangeeta N Bhatia, Ian F Smith, Bruce I Sachs, Bastiano Sanna, Joshua Boger, Peter Mueller, Carmen Bozic, Charles F Wagner Jr, Margaret G Mcglynn, Kristen Ambrose, Elaine Ullian, Bruce Sachs, Stuart A. Arbuckle, Jonathan Biller, Joy Liu, Kenneth L Horton, Megan E Pace, Megan Pace, Jeffrey Leiden, Edward Morrow Atkinson III, Wayne Joseph Riley, Thomas Graney, Mark E Bunnage, Paul Silva, Christiana Stamoulis, Lloyd Carney, Terrence C Kearney, Thomas Connolly, Jeffrey M. Leiden, Kenneth Horton, Paul M. Silva, Ian F. Smith, William D Young, Duncan Mckechnie, and Sangeeta N. Bhatia
The most active insider trader at Vertex Pharmaceuticals Inc is Joshua S Boger with 99 trades.
Jeffrey M Leiden has sold the most Vertex Pharmaceuticals Inc stock with a total value of $395,375,749.22.
Reshma Kewalramani has bought the most Vertex Pharmaceuticals Inc stock with a total value of $17,310,520.00.
The most recent insider trade for Vertex Pharmaceuticals Inc was on March 13, 2026.
The single biggest insider buy for Vertex Pharmaceuticals Inc was from Reshma Kewalramani with a total value of $7,677,010.00 on July 30, 2024.
The single biggest insider sell for Vertex Pharmaceuticals Inc was from Jeffrey M Leiden with a total value of $37,164,389.02 on July 25, 2022.